Related Experiment Video
Updated: Aug 8, 2026

A Zebrafish Embryo Model for In Vivo Visualization and Intravital Analysis of Biomaterial-associated Staphylococcus aureus Infection
Published on: January 7, 2019
Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants
C R Arciola1, D Campoccia, Y H An
1Research Unit on Implant Infections, Rizzoli Orthopedic Institute, Bologna, Italy. carlarenata.arciola@ior.it
Abstract:
Several species belonging to Staphylococcus genus (non Sau/ non Sep species) exhibit increasing abilities as opportunistic pathogens in colonisation of periprosthesis tissues. Here we report on antibiotic resistance of 193 strains, belonging to non Sau/ non Sep species, consecutively collected from orthopedic implant infections in a period of about 40 months. The 193 strains (representing 17% of all staphylococci isolated) were analysed for their antibiotic resistance to 16 different drugs. Five species turned out more prevalent, ranging from 1 to 5%: S. hominis (4.2%), S. haemolyticus (3.7%), S. capitis (2.7%), S. warneri (2.6%), and S. cohnii (1.6%). Among these, the prevalence of antibiotic resistance to penicillins was similar, ranging from 51% to 66%. Conversely, significant differences were observed for all the remaining antibiotics. For S. haemolyticus the resistances to oxacillin and imipenem, the four aminoglycosides and erythromycin were at least twice that of the other three species which were compared. S. warneri was on the contrary the species with the lowest occurrence of resistant strains. Ten species appeared only rarely at the infection sites: S. lugdunensis, S. caprae, S. equorum, S. intermedius, S. xylosus, S. simulans, S. saprophyticus, S. pasteuri, S. sciuri, and S. schleiferi. The behaviours of these species, often resistant to penicillins, were individually analysed. Differences in both the frequencies and the panels of antibiotic resistances observed among the non Sau/ non Sep species: i) suggest that horizontal spreading of resistance factors, if acting, was not sufficient per se to level their bio-diversities; ii) highlight and confirm the worrisome appearance within the Staphylococcus genus of emerging ""new pathogens"", not homogeneous for their virulence and antibiotic resistance prevalence, which deserve to be recognised and treated individually.
Insights
Antibiotic resistance varies significantly among non-aureus, non-septicus Staphylococcus species causing orthopedic infections. Emerging pathogens require individual recognition and treatment strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Opportunistic Staphylococcus species, excluding S. aureus and S. septicus, are increasingly implicated in periprosthetic tissue colonization.
- Understanding the antibiotic resistance profiles of these emerging pathogens is crucial for effective clinical management.
Purpose of the Study:
- To investigate the antibiotic resistance patterns of 193 Staphylococcus strains (non-aureus, non-septicus) isolated from orthopedic implant infections.
- To identify prevalent species and analyze their specific resistance to 16 different antimicrobial drugs.
Main Methods:
- Collection of 193 Staphylococcus strains from orthopedic implant infections over 40 months.
- Analysis of antibiotic resistance against 16 drugs for each isolated strain.
- Identification and prevalence assessment of different Staphylococcus species.
Main Results:
- Five prevalent species identified: S. hominis (4.2%), S. haemolyticus (3.7%), S. capitis (2.7%), S. warneri (2.6%), and S. cohnii (1.6%).
- High penicillin resistance (51-66%) across prevalent species; significant variations in resistance to other antibiotics observed.
- S. haemolyticus showed notably higher resistance to oxacillin, imipenem, aminoglycosides, and erythromycin compared to other species.
Conclusions:
- Differences in antibiotic resistance frequencies suggest limited impact of horizontal gene spread in homogenizing resistance.
- Highlights the emergence of diverse Staphylococcus 'new pathogens' with varied virulence and resistance, necessitating species-specific treatment approaches.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Bacterial Signaling
Development of Antibiotic Resistance
The Oral Microbiota
